In PCa, the tracers used are Choline and Gallium 68 prostatic specific membrane antigen (68Ga-PSMA), the latter proving its superiority in identifying metabolically active metastasis outside the prostate, it identified metastasis in 48% of patients that had negative choline PET-CTs. Here, FOLH1 is linked to posterior cortical atrophy.